MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

10 Feb 2026 Evaluate
The sales declined to Rs. 22836.00 millions for the December 2025 quarter as compared to Rs. 25159.00 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 2965.00 millions from Rs. 4706.00 millions, a decline of -37.00% on QoQ basis.Operating Profit reported a sharp decline to 6728.00 millions from 7260.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 22836.00 25159.00 -9.23 77431.00 92967.00 -16.71 151163.00 108187.00 39.72
Other Income 4738.00 775.00 511.35 15682.00 5654.00 177.36 9058.00 11595.00 -21.88
PBIDT 6728.00 7260.00 -7.33 31087.00 44744.00 -30.52 84325.00 51435.00 63.94
Interest 1160.00 972.00 19.34 3674.00 3085.00 19.09 4639.00 3907.00 18.74
PBDT 4967.00 6288.00 -21.01 26812.00 41659.00 -35.64 79686.00 47442.00 67.97
Depreciation 1443.00 1316.00 9.65 4103.00 3959.00 3.64 5239.00 5044.00 3.87
PBT 3524.00 4972.00 -29.12 22709.00 37700.00 -39.76 74447.00 42398.00 75.59
TAX 559.00 266.00 110.15 4331.00 8088.00 -46.45 16698.00 7983.00 109.17
Deferred Tax -259.00 508.00 -150.98 -200.00 528.00 -137.88 873.00 -1360.00 -164.19
PAT 2965.00 4706.00 -37.00 18378.00 29612.00 -37.94 57749.00 34415.00 67.80
Equity 1006.00 1006.00 0.00 1006.00 1006.00 0.00 1006.00 1006.00 0.00
PBIDTM(%) 29.46 28.86 2.10 40.15 48.13 -16.58 55.78 47.54 17.33
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..